In the murine model of arthritis, BMP inhibition by the systemic gene transfer of noggin—a BMP antagonist, which exerted preventive as well as therapeutic effects, depending on the time of administration (before or after the first symptoms of arthritis) [36]. The gene discussed is NOG; the disease is arthritic joint disease.